PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$1.88
-0.02 (-1.05%)
Open$1.94
Previous Close$1.90
Day High$1.96
Day Low$1.81
52W High$17.95
52W Low$1.80
Volume—
Avg Volume137.9K
Market Cap1.60M
P/E Ratio—
EPS$-12.92
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+536.2% upside
Current
$1.88
$1.88
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.4K | 3.33M | 3.45M |
| Net Income | -6,371,488 | 722.6K | 805.0K |
| Profit Margin | -28,458.8% | 21.7% | 23.3% |
| EBITDA | -5,759,120 | 1.33M | 1.25M |
| Free Cash Flow | — | 449.2K | 396.5K |
| Rev Growth | — | -7.5% | +9.4% |
| Debt/Equity | — | 0.57 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |